Literature DB >> 1341254

Activities of thymidylate synthetase and thymidine kinase in gastric cancer.

T Konishi1, T Miyama, S Sakamoto, T Hirata, K Mafune, M Hiraishi, Y Idezuki.   

Abstract

In a previous clinical study, sequential methotrexate and 5-fluorouracil has shown improved efficacy for treating advanced gastric cancer of the poorly differentiated type. In this study, we investigated whether difference in the levels of thymidylate synthetase (TS) and thymidine kinase (TK) activities in gastric cancer tissue account for selectivity of the treatment. Activity of TS was higher in 19 cases of the poorly differentiated type than in 16 cases of the well differentiated type (P < 0.02), whereas TK activity was lower in the poorly differentiated type than in the well differentiated type (P < 0.01). Thus, the TS/TK ratio was significantly higher in poorly differentiated gastric cancers than in well differentiated cancers (P < 0.001). These results suggest that a greater dependence upon the de novo pathway of pyrimidine synthesis in poorly differentiated gastric carcinomas may enhance the efficacy of sequential methotrexate and 5-fluorouracil treatment.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1341254     DOI: 10.1016/0960-7404(92)90067-u

Source DB:  PubMed          Journal:  Surg Oncol        ISSN: 0960-7404            Impact factor:   3.279


  5 in total

1.  Diagnostic performance of ¹⁸F-fluorothymidine PET/CT for primary colorectal cancer and its lymph node metastasis: comparison with ¹⁸F-fluorodeoxyglucose PET/CT.

Authors:  Masatoyo Nakajo; Masayuki Nakajo; Yoriko Kajiya; Megumi Jinguji; Nobuaki Nishimata; Shunji Shimaoka; Tohru Nihara; Kuniaki Aridome; Sadao Tanaka; Yoshihiko Fukukura; Atushi Tani; Chihaya Koriyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-05-08       Impact factor: 9.236

2.  A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501).

Authors:  Norisuke Nakayama; Wasaburo Koizumi; Satoshi Tanabe; Tohru Sasaki; Katsunori Saigenji
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

3.  Detection of gastric cancer using 18F-FLT PET: comparison with 18F-FDG PET.

Authors:  Reiko Kameyama; Yuka Yamamoto; Kunihiko Izuishi; Ryusuke Takebayashi; Masanobu Hagiike; Makiko Murota; Masato Kaji; Reiji Haba; Yoshihiro Nishiyama
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-11-05       Impact factor: 9.236

4.  Gastric phenotype signet-ring cell carcinoma of the stomach with multiple bone metastases effectively treated with sequential methotrexate and 5-fluorouracil.

Authors:  Tsutomu Mizoshita; Hiromi Kataoka; Eiji Kubota; Yasuyuki Okamoto; Takaya Shimura; Yoshinori Mori; Tsuneya Wada; Naotaka Ogasawara; Makoto Sasaki; Takeshi Kamiya; Takashi Joh
Journal:  Int J Clin Oncol       Date:  2008-08-15       Impact factor: 3.402

5.  Immunohistochemical expression of thymidylate synthase and prognosis in gastric cancer patients submitted to fluoropyrimidine-based chemotherapy.

Authors:  Marina Alessandra Pereira; Marcus Fernando Kodama Pertille Ramos; Andre Roncon Dias; Sheila Friedrich Faraj; Cinthya Dos Santos Cirqueira; Evandro Sobroza de Mello; Bruno Zilberstein; Venancio Avancini Ferreira Alves; Ulysses Ribeiro
Journal:  Chin J Cancer Res       Date:  2018-10       Impact factor: 5.087

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.